Australia markets open in 1 hour 13 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
153.16-0.98 (-0.64%)
At close: 04:03PM EDT
152.94 -0.22 (-0.14%)
After hours: 06:28PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close154.14
Bid151.83 x 800
Ask153.20 x 900
Day's range150.87 - 154.04
52-week range105.56 - 175.91
Avg. volume7,361,304
Market cap270.651B
Beta (5Y monthly)0.81
PE ratio (TTM)21.97
EPS (TTM)6.97
Earnings date28 July 2022 - 01 Aug 2022
Forward dividend & yield5.64 (3.66%)
Ex-dividend date14 July 2022
1y target est163.01
  • Editor's pick
    Yahoo Finance Video

    Moody’s reduces outlook for pharma industry, Pfizer to provide additional COVID vaccine doses

    Yahoo Finance's Anjalee Khemlani joins the Live show to discuss Moody's outlook for pharmaceutical industry as well as reports that Pfizer is looking to provide additional COVID-19 vaccine doses.

  • Motley Fool

    2 of the Safest Stocks to Buy in a Recession

    Shares of AbbVie (NYSE: ABBV) are up by about 13% this year, which is a lot better than the benchmark S&P 500 index, which has lost 20% over the same period. With lots of high-margin revenue from top-selling drugs, there's a good chance that AbbVie stock will remain a safe haven even if the U.S. economy plunges into a deep recession. The top-selling drug for AbbVie is Humira.

  • Motley Fool

    The Best Stocks to Invest $5,000 in Right Now

    Let's look at two stocks worth investing $5,000 in right now for investors who want to score market-beating returns in the long run: AbbVie (NYSE: ABBV) and Intuitive Surgical (NASDAQ: ISRG). Shares of AbbVie have easily outperformed the market this year, but the company remains reasonably valued. At these levels, AbbVie is an outstanding stock to buy considering the strength of its underlying business.